|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Babjuk M, Böhle A, Burger M, Capoun O,
Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M,
et al: EAU guidelines on non-muscle-invasive urothelial carcinoma
of the bladder: Update 2016. Eur Urol. 3:447–461. 2017. View Article : Google Scholar
|
|
3
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmström PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chester JD, Hall GD, Forster M and
Protheroe AS: Systemic chemotherapy for patients with bladder
cancer - current controversies and future directions. Cancer Treat
Rev. 30:343–358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Budman LI, Kassouf W and Steinberg JR:
Biomarkers for detection and surveillance of bladder cancer. Can
Urol Assoc J. 2:212–221. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hart L, Rauch A, Carr AM, Vermeesch JR and
O'Driscoll M: LETM1 haploinsufficiency causes mitochondrial defects
in cells from humans with Wolf-Hirschhorn syndrome: Implications
for dissecting the underlying pathomechanisms in this condition.
Dis Model Mech. 7:535–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Endele S, Fuhry M, Pak SJ, Zabel BU and
Winterpacht A: LETM1, a novel gene encoding a putative EF-hand
Ca2+−-binding protein, flanks the Wolf-Hirschhorn
syndrome (WHS) critical region and is deleted in most WHS patients.
Genomics. 60:218–225. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piao L, Li Y, Kim SJ, Byun HS, Huang SM,
Hwang SK, Yang KJ, Park KA, Won M, Hong J, et al: Association of
LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP
production and necrotic cell death. Cancer Res. 69:3397–3404. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, Yang Y, Liu S, Piao L, Zhang Y,
Lin Z and Li Z: High expression of leucine zipper-EF-hand
containing transmembrane protein 1 predicts poor prognosis in head
and neck squamous cell carcinoma. Biomed Res Int.
2014:8503162014.PubMed/NCBI
|
|
10
|
Wang CA, Liu Q, Chen Y, Liu S, Xu J, Cui
X, Zhang Y and Piao L: Clinical implication of leucine zipper/EF
hand-containing transmembrane-1 overexpression in the prognosis of
triple-negative breast cancer. Exp Mol Pathol. 98:254–259. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahmad I: The role of WNT signalling in
urothelial cell carcinoma. Ann R Coll Surg Engl. 97:481–486. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pierzynski JA, Hildebrandt MA, Kamat AM,
Lin J, Ye Y, Dinney CP and Wu X: Genetic variants in the
Wnt/β-catenin signaling pathway as indicators of bladder cancer
risk. J Urol. 194:1771–1776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Costello JC and Theodorescu D: Decade in
review-bladder cancer: International progress: From cytology to
genomics. Nat Rev Urol. 11:609–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li N, Zheng Y, Xuan C, Lin Z, Piao L and
Liu S: LETM1 overexpression is correlated with the clinical
features and survival outcome of breast cancer. Int J Clin Exp
Pathol. 8:12893–12900. 2015.PubMed/NCBI
|
|
15
|
Doonan PJ, Chandramoorthy HC, Hoffman NE,
Zhang X, Cárdenas C, Shanmughapriya S, Rajan S, Vallem S, Chen X,
Foskett JK, et al: LETM1-dependent mitochondrial Ca2+
flux modulates cellular bioenergetics and proliferation. FASEB J.
28:4936–4949. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dimmer KS, Navoni F, Casarin A, Trevisson
E, Endele S, Winterpacht A, Salviati L and Scorrano L: LETM1,
deleted in Wolf-Hirschhorn syndrome is required for normal
mitochondrial morphology and cellular viability. Hum Mol Genet.
17:201–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HS, Nie X, Wu RB, Yuan HW, Ma YH, Liu
XL, Zhang JY, Deng XL, Na Q, Jin HY, et al: Downregulation of human
Wnt3 in gastric cancer suppresses cell proliferation and induces
apoptosis. Onco Targets Ther. 9:3849–3860. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li K, Zhou ZY, Ji PP and Luo HS: Knockdown
of β-catenin by siRNA influences proliferation, apoptosis and
invasion of the colon cancer cell line SW480. Oncol Lett.
11:3896–3900. 2016.PubMed/NCBI
|
|
19
|
Wu D, Li L and Yan W: Knockdown of TC-1
enhances radiosensitivity of non-small cell lung cancer via the
Wnt/β-catenin pathway. Biol Open. 5:492–498. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klein EA and Assoian RK: Transcriptional
regulation of the cyclin D1 gene at a glance. J Cell Sci.
121:3853–3857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin X, Zhang H, Zhou X, Wang C, Zhang H,
Zhang X and Ye L: Proliferation and migration mediated by
Dkk-1/Wnt/β-catenin cascade in a model of hepatocellular carcinoma
cells. Transl Res. 150:281–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cicatiello L, Addeo R, Sasso A, Altucci L,
Petrizzi VB, Borgo R, Cancemi M, Caporali S, Caristi S, Scafoglio
C, et al: Estrogens and progesterone promote persistent CCND1 gene
activation during G1 by inducing transcriptional derepression via
c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex
assembly to a distal regulatory element and recruitment of cyclin
D1 to its own gene promoter. Mol Cell Biol. 24:7260–7274. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stine ZE, Walton ZE, Altman BJ, Hsieh AL
and Dang CV: MYC, metabolism and cancer. Cancer Discov.
5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
|
